Journal
JOURNAL OF IMMUNOLOGY
Volume 175, Issue 1, Pages 319-328Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.175.1.319
Keywords
-
Categories
Funding
- NIAMS NIH HHS [R03AR050017] Funding Source: Medline
- NIA NIH HHS [P01AG01743] Funding Source: Medline
- NIDCR NIH HHS [R01 DE017568] Funding Source: Medline
- NIGMS NIH HHS [R01GM44809] Funding Source: Medline
Ask authors/readers for more resources
Delta BAFF is a novel splicing isoform of the regulator B cell-activating factor (BAFF, BLyS), a TNF family protein with powerful immunoregulatory effects. Overexpression of BAFF leads to excessive B cell accumulation, activation, autoantibodies, and lupus-like disease, whereas an absence of BAFF causes peripheral B cell immunodeficiency. Based on the ability of Delta BAFF to multimerize with full-length BAFF and to limit BAFF proteolytic shedding from the cell surface, we previously proposed a role for Delta BAFF in restraining the effects of BAFF and in regulating B lymphocyte homeostasis. To test these ideas we generated mice transgenic for Delta BAFF under the control of human CD68 regulatory elements, which target expression to myeloid and dendritic cells. We also generated in parallel BAFF transgenic mice using the same expression elements. Analysis of the transgenic mice revealed that Delta BAFF and BAFF had opposing effects on B cell survival and marginal zone B cell numbers. Delta BAFF transgenic mice had reduced B cell numbers and T cell-dependent Ab responses, but normal preimmune serum Ig levels. In contrast, BAFF transgenic mice had extraordinarily elevated Ig levels and increases in subsets of B cells. Unexpectedly, both BAFF and-Delta BAFF appeared to modulate the numbers of B-1 phenotype B cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available